Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 26 (NPM1P26)

Target
NPM1P26
Molecular classification
Other (pseudogene)
01

Overview

Nucleophosmin 1 pseudogene 26 (NPM1P26) is a pseudogene—that is, a genomic DNA sequence similar to the NPM1 gene but typically non-functional and does not produce a functional protein product. Pseudogenes usually result from gene duplication or retrotransposition but lose coding capacity due to mutations. There is currently no evidence that NPM1P26 serves as a therapeutic target, is involved in human disease, or interacts with any drugs. Standard biological classification does not include NPM1P26 as a member of functionally-defined gene families such as receptors, enzymes, or transcription factors. There are no known utility, biomarker roles, or safety concerns associated with NPM1P26. This entry is not considered a canonical therapeutic target, and there does not appear to be significant published information or biomedical relevance associated with NPM1P26. If you are searching for the related protein-coding gene, you may be interested in “Nucleophosmin 1 (NPM1),” a nucleolar phosphoprotein with roles in ribosome biogenesis and cancer biology, which is entirely distinct from this pseudogene.

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 26 (NPM1P26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 26 (NPM1P26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call